STEAP2 inhibitors for the treatment of liver cancers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11168327
APP PUB NO 20190352646A1
SERIAL NO

16481950

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are methods for the diagnosis and treatment of liver cancers such as hepatocellular carcinoma (HCC). In some aspects, the methods comprise administering an inhibitor of STEAP2 to a subject to treat a liver cancer. In some embodiments, a STEAP2 targeting siRNA or antibody is administered to a subject to treat HCC.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RESEARCH DEVELOPMENT FOUNDATION402 NORTH DIVISION STREET CARSON CITY NV 89703

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cigarroa, Francisco San Antonio, US 1 0
Gu, Xiang San Antonio, US 11 37
Sun, Luzhe San Antonio, US 4 44
Torrez, Carla Zeballos San Antonio, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 9, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 May 9, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 9, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00